MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-06-0015243
Raks Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹224.6 Cr
▼ 25% YoY
Net profit · FY 2025
₹13.59 Cr
Net margin 6.1%
EBITDA · FY 2025
₹42.33 Cr
EBITDA margin 18.8%
Authorised capital
₹1.75 Cr
Registered with MCA
Paid-up capital
₹1.62 Cr
Issued & subscribed
Satisfied charges
₹16.76 Cr
No open charges
Company age
18 yrs
Est. 2008
Employees · EPFO
467
Provident fund records
About Raks Pharma Private Limited
Data last updated:
Raks Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Amneal Singapore Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 22 October 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2008PTC068526. Its GSTIN is 24AAECR6025P1Z3 (Gujarat). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹1.75 Cr and a paid-up capital of ₹1.62 Cr. It is led by directors including Rajeev Midha and Suresh Punambhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 901 – 911 Iscon Elegance Opp. Karnavati Club S.G.Highway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹224.6 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹13.59 Cr (net margin 6.1%) and EBITDA of ₹42.33 Cr (EBITDA margin 18.8%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 5% over five years.
The company has about 467 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Raks Pharma. As per MCA filings, the company has satisfied charges of ₹16.76 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹50.26 Cr; the latest was in May 2014. The company has 18 MSME Form 1 returns on record between 2010 and 2023, listing 395 overdue payments to 98 micro and small suppliers.
Raks Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0015243). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rakspharma.com.
Company details
CIN U24233GJ2008PTC068526
Registration Number 068526
Incorporation Date 22 October 2008
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Amneal Singapore Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-06-0015243
CIN history
Raks Pharma has one previous CIN (Corporate Identification Number): U24233AP2008PTC061508. The current CIN is U24233GJ2008PTC068526, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233GJ2008PTC068526 | Current |
| U24233AP2008PTC061508 | Previous |
Recognitions & Rankings of Raks Pharma
Contact details
Raks Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is rakspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address901 – 911 Iscon Elegance Opp. Karnavati Club S.G.Highway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, API Manufacturers
To see the full contact details of Raks Pharma Private Limited, buy the company report.
Comprehensive company report
Raks Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Raks Pharma operates one associated brand: Raks Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies pharmaceutical ingredients and intermediates for industry needs. | rakspharma.com |
Business activity
The main business activities of Raks Pharma are professional, scientific and technical and manufacturing. In detail, this covers scientific research and development and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Raks Pharma Private Limited, buy the company report.
Financials of Raks Pharma Private Limited
FY 2024 filings availableRaks Pharma Private Limited reported revenue of ₹224.6 Cr (down 25% YoY) for FY 2025.
Revenue · FY 2025
₹224.6 Cr ▼ 25%
Net profit · FY 2025
₹13.59 Cr margin 6.1%
EBITDA · FY 2025
₹42.33 Cr margin 18.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▲ 13%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 65%
3 years · compounded
▲ 28%
5 years · compounded
▲ 7%
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.8% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raks Pharma Private Limited, buy the company report.
Board of directors of Raks Pharma Private Limited
Raks Pharma has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Midha Also directs: Amneal Oncology Private Limited, Amneal Pharmaceuticals Private Limited, Amneal Healthcare Private Limited and 2 more | Director | 25 Jan 2019 | 7 Years 9 Months | Current |
| Suresh Punambhai Patel Also directs: Kayura Effect LLP, Shivanka Research Private Limited, Amneal Oncology Private Limited and 5 more | Director | 30 Jul 2010 | 16 Years 2 Months | Current |
| Rahul Maitra Also directs: Amneal Oncology Private Limited, Amneal Pharmaceuticals Private Limited, Amneal Healthcare Private Limited and 3 more | Director | 14 May 2024 | 2 Years 5 Months | Current |
| Sandeep Radhakisan Raktate Also directs: Amneal Oncology Private Limited, Amneal Pharmaceuticals Private Limited, Amneal Healthcare Private Limited and 3 more | Director | 14 May 2024 | 2 Years 5 Months | Current |
Auditor
Raks Pharma Private Limited is audited by Chandulal M. Shah & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chandulal M. Shah & Co. | FY 2023 | 101698W |
Shareholding
The shareholding of Raks Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Raks Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹16.76 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Feb 2010 | 10203434 | Union Bank of India | ₹16.76 Cr | Satisfied |
To see the full charge records of Raks Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Raks Pharma Private Limited has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹50.26 Cr; the latest was in May 2014.
Total deals
5
Secondary share transfers
3
Funding rounds
2
Disclosed funding
₹50.26 Cr
Deals on record (4 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2013 | Secondary share transfer | Undisclosed | Buyer: Amneal Singapore Pvt Ltd Seller: Amneal Pharma Investments Holding |
| Sep 2012 | Funding round | ₹11.94 Cr | Investors: Amneal Pharma Investments Holding |
| Oct 2010 | Funding round | ₹38.31 Cr | Investors: Amneal Pharma Investments Holding |
| Aug 2010 | Secondary share transfer | Undisclosed | Buyer: Amneal International, Amneal Pharma Investments Holding Seller: 4 individuals |
To see the full deal history of Raks Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Raks Pharma Private Limited has 4 court cases on record: 3 filed by Raks Pharma, 1 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
3
Filed against the company
1
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 1 |
| District courts | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against an individual | Pending |
| District court, Bharuch, Gujarat | Criminal complaint | Filed against the company by an individual | Disposed |
| High Court, TELANGANA | Company petition | Filed by the company | Disposed |
| High Court, TELANGANA | Court case (COMPA) | Filed by the company | Disposed |
To see the full case history of Raks Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Raks Pharma Private Limited has 18 MSME Form 1 returns on record between 2010 and 2023, listing 395 overdue payments to 98 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 98)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Mahadev Industrial Service | |||
| Unistar Environment and Research Labs Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Raks Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Raks Pharma Private Limited has a workforce of 467 employees on its EPFO records as of Mar 31, 2024, across 3 active EPFO establishments.
Employee count
467
Active EPFO establishments
3
Employee growth
-3.51%
GST
Raks Pharma has 4 GST registrations: 4 active.
Total GSTINs
4
Active
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECR6025P1Z3 | Gujarat | Active | 01 Jul 2017 |
| 24AAECR6025P2Z2 | Gujarat | Active | 10 Jul 2017 |
| 24AAECR6025P3Z1 | Gujarat | Active | 17 Mar 2025 |
| 37AAECR6025P1ZW | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Raks Pharma Private Limited, buy the company report.
Recent activity
Raks Pharma Private Limited has 14 board changes on record since 2010: 4 appointments and 10 cessations. The latest: Rahul Maitra ceased to be Additional Director on 29 Sep 2024.
AGM
Raks Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Rahul Maitra ceased to be Additional Director.
Ceased
Sandeep Radhakisan Raktate ceased to be Additional Director.
Appointed
Rahul Maitra was appointed as Director.
Appointed
Sandeep Radhakisan Raktate was appointed as Director.
Filing
Raks Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Ceased
Rajeev Midha ceased to be Additional Director.
Ceased
Sanjay Kumar Jain ceased to be Additional Director.
Ceased
Kanwal Pushkarnath Pandita ceased to be Director.
Ceased
Pankil Narendrakumar Patel ceased to be Director.
Ceased
Nikunj Bansibhai Patel ceased to be Director.
Appointed
Rajeev Midha was appointed as Director.
8 earlier events are in the company report.
Frequently asked questions
Raks Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 22 October 2008 (18+ years old) and is registered under CIN U24233GJ2008PTC068526.
Raks Pharma has 4 current directors:
- Rajeev Midha - Director
- Suresh Punambhai Patel - Director
- Rahul Maitra - Director
- Sandeep Radhakisan Raktate - Director
The latest financial statements of Raks Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Raks Pharma is 24AAECR6025P1Z3, registered in Gujarat. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 24AAECR6025P2Z2 (Gujarat), 24AAECR6025P3Z1 (Gujarat), 37AAECR6025P1ZW (Andhra Pradesh).
The CIN (Corporate Identification Number) of Raks Pharma is U24233GJ2008PTC068526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raks Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Raks Pharma was incorporated on 22 October 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Raks Pharma has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹50.26 Cr; the latest was in May 2014.
Rahul Maitra ceased to be Additional Director on 29 Sep 2024. Sandeep Radhakisan Raktate ceased to be Additional Director on 29 Sep 2024. Rahul Maitra was appointed as Director on 14 May 2024. Raks Pharma has 14 board changes on record in total.
Yes, Raks Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0015243).
Raks Pharma has 18 MSME Form 1 returns on record between 2010 and 2023, listing 395 overdue payments to 98 micro and small suppliers. The latest return was filed on 16 Dec 2023.